TCW Group’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-4,483	Closed	-$2.38M	–	762
2013 Q3	$2.38M	Sell	4,483 -14,890	-77%	-$7.91M	0.01%	635
2013 Q2	$4.54M	Buy	+19,373	New	+$4.54M	0.02%	494